AI in Healthcare Track Day One

 

AI in Healthcare 2018 Day One

Opening keynotes – AI in healthcare

09:00

Opening remarks from Terrapinn

09:10

How will AI disrupt the healthcare industry?

Reserved for supporting partner
Please contact Derek Cavanagh derek.cavanagh@terrapinn.com or Alistair Wilmot alistair.wilmot@terrapinn.com if interested in sponsoring​
Philipp M Diesinger
10:10

Artificial Intelligence transforming pharma and healthcare

Reserved for supporting partner
Please contact Derek Cavanagh derek.cavanagh@terrapinn.com or Alistair Wilmot alistair.wilmot@terrapinn.com if interested in sponsoring
Philipp M Diesinger, Global Chief Data Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG
10:30

Reserved for supporting partner

Reserved for supporting partner
Please contact Derek Cavanagh derek.cavanagh@terrapinn.com or Alistair Wilmot alistair.wilmot@terrapinn.com if interested in sponsoring

10:50 Networking Break

round tables
11:50

AI round table discussion session

  • Table 1: Transforming health care delivery through artificial intelligence
  • William Paiva

    William Paiva, Executive Director, Center for Health Systems Innovation, Oklahoma State University

  • Table 2: Is AI safety akin to clinical safety? Current issues in healthcare governance
  • Sam Smith

    Sam Smith, Co-ordinator, MedConfidential

  • Table 3: Investing in healthcare: emerging and exponential technologies
  • Dmitry Kaminskiy

    Dmitry Kaminskiy, Founding Partner, Deep Knowledge Ventures

  • Table 4: Solutions on sharing data
  • Table 5: How will we regulate AI?
  • Table 6: Making the patient experience better with AI
  • 13:10 Networking lunch

    AI pharma and research - drug discovery and biomarkers

    Healthcare delivery - using AI in hospitals

    AI for pharma and research
    14:40

    Integrative big data for drug discovery

    • Innovation in drug discovery is becoming increasingly challenging requiring comprehensive objective decision making
    • Cancer therapy is becoming increasingly complex with drug resistance and tumor heterogeneity and tumor evolution
    • We have developed integrative data and machine learning / AI approaches to address some key bottle necks in drug discovery and adaptive cancer therapy
     
    Using AI in hospitals
    14:40

    Our partnership with Deepmind

    •     Current use of the Streams application
    •     Future development of the Streams application
    Using AI in hospitals
    15:00

    Using AI to improve healthcare

    • The challenges in social care
    • How social care needs to change
    • Where AI fits into social care
     
    AI for pharma and research
    15:20

    Using our technology to speed up drug discovery

    Reserved for supporting partner
    Please contact Derek Cavanagh derek.cavanagh@terrapinn.com or Alistair Wilmot alistair.wilmot@terrapinn.com if interested in sponsoring
    Using AI in hospitals
    15:20

    Data analytics and AI for healthcare transformation

    • The healthcare crisis can only be addressed if healthcare model is transformed
    • Value-based healthcare is the new paradigm
    • Data are essential to implement the new model
    • Business intelligence and AI are two basic tools for value-based healthcare
    • A specific architecture for simulation, emulation and big data set generation will be presented
     
    AI for pharma and research
    15:40

    Improving translation rates into the clinic through AI modeling of ADME/Tox

    • Discuss the current state-of-the-art modeling of ADME and toxicity
    • Examine some of the challenges/wins in applying AI modeling to ADME and toxicity
    • Explore case studies involving the use of these models to solve key challenges
     
    Using AI in hospitals
    15:40

    Making diagnostics quantitative and intelligent using AI and machine learning

    Senior Representative, Viz.AI
     

    16:00 Networking Break

    AI for pharma and research
    17:20

    Digitised biology and image analysis augment drug discovery

    • What does it mean to ‘see’ for a machine?
    • Impact of AI in image and video analysis for pharmaceutical industry
    • Our work in image analysis is currently focusing on a range of enabling topics in computer vision, image processing and pattern recognition with the goal of automation
     
    Using AI in hospitals
    17:20

    Artificial Intelligence at the point of care

    • GOFAI: Good Old Fashioned AI has had many successes but has struggled to get professional adoption in healthcare
    • NEWFAI: New Fangled AI (or machine intelligence) promises a revolution but will face its own challenges
    • Human centred cognitive systems combine the strengths of both – time to invest?
     
    AI for pharma and research
    17:40

    In silico prediction of novel therapeutic targets using gene – disease association data

    • Many target identification programmes that fail for efficacy reasons showing poor association between the drug target and the disease
    • We used a semi-supervised classification approach to explore whether gene – disease association data from the Open Targets platform is sufficient to predict therapeutic targets that are actively being pursued by pharmaceutical companies or are already on the marke.
    • We show that a neural network is able to predict therapeutic targets with over 70% accuracy demonstrating that disease association is predictive of the ability of a gene or a protein to work as a drug target
     
    Using AI in hospitals
    17:40

    Using the cloud to power medical imaging

    Reserved for supporting partner
    Please contact Derek Cavanagh derek.cavanagh@terrapinn.com or Alistair Wilmot alistair.wilmot@terrapinn.com if interested in sponsoring
     
     
    AI for pharma and research
    18:00

    Modeling pharmaceutical drug discovery datasets with machine learning

    • Application of neural networks to pharmaceutical datasets
    • Comparison of deep-learning based approaches to baseline methods
    • Discussion of relevant issues when applying machine learning in an industrial setting
     
     
    Using AI in hospitals
    18:00

    The Wearable Clinic: Digital phenotyping using mobile health technologies

    • People with long-term conditions interact with the NHS through rigid pathways that poorly match the dynamic nature of their condition
    • Our vision is to enable new forms of collaborative care through dynamic personal care plans and mobile/wearable health technologies
    • Focusing on patients with servere mental illness, we present machine learning algorithms to assess social functioning and risk of psychotic relapse using community-acquired geolocation data

    18:20 Offsite drinks reception

    last published: 13/Dec/17 09:35 GMT

     

     

    The World Precision Medicine Congress is both a world-class conference, bringing together hundreds of pharma, biotech and academic leaders from around the globe, and a fantastic exhibition showcasing the newest technologies, developments and solutions. There is a registration fee to attend the congress, however the exhibition is absolutely free to attend 

    CONTACT US 
    phone: +44 (0)207 092 1134 
    email: 
      
    joan.shutt@terrapinn.com